Antiviral activity of arbidol hydrochloride against herpes simplex virus I in vitro and in vivo-Reference-Cited by-同舟云学术

Antiviral activity of arbidol hydrochloride against herpes simplex virus I in vitro and in vivo

Published:2018-01 Issue:1 Volume:51 Page:98-106
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Li Min-ke,Liu Yuan-yuan,Wei Fei,Shen Meng-xin,Zhong Yan,Li Shan,Chen Liang-jun,Ma Nian,Liu Bing-yu,Mao Yi-dong,Li Ning,Hou Wei,Xiong Hai-rong,Yang Zhan-qiu

Funder

Major Program for Technique Development Research of Novel Medicine Production

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference31 articles.

1. Herpes simplex viruses;Roizman,2013

2. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review;Smith;J Infect Dis,2002

3. Cell entry mechanisms of HSV: what we have learned in recent years;Agelidis;Future Virol,2015

4. Antiviral agents for herpes simplex virus;Vere Hodge;Adv Pharmacol,2013

5. CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections;Prichard;Antimicrob Agents Chemother,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positively charged mesoporous silica nanocarriers loaded with arbidol: A novel effective nano antiviral system against nervous necrosis virus;Aquaculture;2025-01

2. Joule Heating-Induced Active Mg⁰ into Nano-Mg Composites for Boosted Oxidation and Antiviral Performance;ACS ES&T Engineering;2024-04-24

3. ‘Getting Better’—Is It a Feasible Strategy of Broad Pan-Antiherpesviral Drug Targeting by Using the Nuclear Egress-Directed Mechanism?;International Journal of Molecular Sciences;2024-02-29

4. Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies;RSC Medicinal Chemistry;2024

5. Inhibition of herpes simplex virus by wedelolactone via targeting viral envelope and cellular TBK1/IRF3 and SOCS1/STAT3 pathways;International Journal of Antimicrobial Agents;2023-12